Golubeva Julia A, Sheptulina Anna F, Elkina Anastasia Yu, Liusina Ekaterina O, Kiselev Anton R, Drapkina Oxana M
Department of Fundamental and Applied Aspects of Obesity, National Medical Research Center for Therapy and Preventive Medicine, 101990 Moscow, Russia.
Department of Therapy and Preventive Medicine, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
Biomedicines. 2023 Sep 5;11(9):2465. doi: 10.3390/biomedicines11092465.
Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.
非酒精性脂肪性肝病（NAFLD）和动脉高血压（AH）是全球人群中广泛存在的非传染性疾病。由于高血压和NAFLD是与代谢综合征相关的疾病，它们常常合并存在。事实上，许多当代发表的研究证实了这些疾病之间的关联，无论是否存在其他代谢因素，如肥胖、血脂异常和2型糖尿病。这篇叙述性综述探讨了NAFLD与AH之间关联的特征以及可能的病理生理机制。
